Waters Corp (WAT)

$374.68 -7.73 (-2.02%)
Market Cap 36.79B
Revenue (ttm) 3.17B
Net Income (ttm) 642.63M
EPS (ttm) N/A
PE Ratio 28.16
Forward PE 26.36
Profit Margin 20.30%
Debt to Equity Ratio 0.32
Volume 819,100
Avg Vol 937,946
Day's Range N/A - N/A
Shares Out 98.19M
Stochastic %K 66%
Beta 1.20
Analysts Strong Sell
Price Target $414.87

Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 508 478 2000
Fax: 508 872 1990
Address:
34 Maple Street, Milford, United States
prismmarketview
prismmarketview Jul. 20 at 6:57 PM
Women's oncology is entering a new growth phase. A new PwC report projects the market could approach $110 billion by 2030, with investment increasingly expanding beyond breast cancer into ovarian, cervical and endometrial cancers. Our latest examines the trends driving the sector and highlights public companies advancing innovation across earlier detection, targeted therapies and immuno-oncology. $WAT $CORT $VSTM $IMNN $BLRX https://prismmarketview.com/womens-oncology-is-entering-its-next-growth-phase-as-investment-moves-beyond-breast-cancer/
0 · Reply
UpgradeDowngrade
UpgradeDowngrade Jul. 10 at 2:26 PM
$WAT RBC Capital Mkts has altered their rating of "Outperform" and target of "$435" see consensus outlook
0 · Reply
UpgradeDowngrade
UpgradeDowngrade Jun. 30 at 2:29 AM
$WAT Bernstein has altered their rating of "Outperform" and target of "$435" see consensus outlook
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 3:26 PM
$WAT Current Stock Price: $357.98 Contracts to trade: $360.0 WAT Jul 17 2026 Call Entry: $11.90 Exit: $20.68 ROI: 74% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 22 at 6:15 PM
$WAT Share Price: $357.77 Contract Selected: Jan 15, 2027 $360 Calls Buy Zone: $31.62 – $39.06 Target Zone: $56.95 – $69.60 Potential Upside: 70% ROI Time to Expiration: 206 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BreakoutsHappen
BreakoutsHappen Jun. 5 at 4:51 AM
Watchlist Today $ILMN $CZR $LSTR $WAT https://breakoutshappen.com/scanners/vcp-scanner
0 · Reply
JFDI
JFDI Jun. 3 at 4:58 PM
$WAT big ol base
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Jun. 1 at 6:44 PM
$WAT These medical device stocks have 2 to 3 Green Day’s per month
0 · Reply
flychicken1991
flychicken1991 Jun. 1 at 12:06 PM
news impact: Waters unveiled the Cyclic IMS P20 MS platform for structural and spatial omics, putting instrument adoption and lab workflow upgrades in focus. NewsImpact map: https://clawpool.hihired.org/newsimpact/?ticker=WAT&utm_source=stocktwits&utm_medium=parent_url Watch launch timing, customer uptake, omics workflow demand, margin mix, and life-science tools peer reaction. Not financial advice.$WAT
0 · Reply
Skusek
Skusek May. 31 at 11:21 PM
$WAT Target 400-450$
0 · Reply
Latest News on WAT
Waters price target raised to $408 from $385 at TD Cowen

2026-07-15T12:45:32.000Z - 11 days ago

Waters price target raised to $408 from $385 at TD Cowen

Waters price target raised to $425 from $380 at Goldman Sachs

2026-07-14T10:16:10.000Z - 12 days ago

Waters price target raised to $425 from $380 at Goldman Sachs

Waters price target raised to $390 from $350 at Morgan Stanley

2026-07-09T11:05:53.000Z - 17 days ago

Waters price target raised to $390 from $350 at Morgan Stanley

Waters initiated with an Outperform at RBC Capital

2026-07-08T20:45:16.000Z - 18 days ago

Waters initiated with an Outperform at RBC Capital

Waters price target raised to $410 from $380 at Evercore ISI

2026-07-06T12:50:31.000Z - 20 days ago

Waters price target raised to $410 from $380 at Evercore ISI

Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call

Jul 2, 2026, 6:00 AM EDT - 24 days ago

Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call

Waters resumed with an Outperform at Bernstein

2026-06-26T10:30:51.000Z - 4 weeks ago

Waters resumed with an Outperform at Bernstein

IMU Biosciences, Waters announce strategic partnership

2026-06-24T12:10:32.000Z - 4 weeks ago

IMU Biosciences, Waters announce strategic partnership

Waters and IMU Biosciences announce strategic partnership

2026-06-24T12:05:26.000Z - 4 weeks ago

Waters and IMU Biosciences announce strategic partnership

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Jun 24, 2026, 8:00 AM EDT - 4 weeks ago

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Waters initiated with a Neutral at Piper Sandler

2026-06-11T09:55:54.000Z - 6 weeks ago

Waters initiated with a Neutral at Piper Sandler

Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis

Jun 9, 2026, 8:00 AM EDT - 6 weeks ago

Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

Jun 8, 2026, 8:00 AM EDT - 6 weeks ago

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

Waters Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 10:30 AM EDT - 7 weeks ago

Waters Transcript: Jefferies Global Healthcare Conference 2026

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

Jun 3, 2026, 8:00 AM EDT - 7 weeks ago

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

Waters price target raised to $435 from $415 at HSBC

2026-06-03T09:33:35.000Z - 7 weeks ago

Waters price target raised to $435 from $415 at HSBC

Waters price target raised to $400 from $370 at BofA

2026-06-02T11:36:54.000Z - 7 weeks ago

Waters price target raised to $400 from $370 at BofA

Waters assumed with an Outperform at Wolfe Research

2026-06-01T21:08:35.000Z - 7 weeks ago

Waters assumed with an Outperform at Wolfe Research

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Jun 1, 2026, 8:00 AM EDT - 7 weeks ago

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Jun 1, 2026, 8:00 AM EDT - 7 weeks ago

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Corporation to Present at the Jefferies Global Healthcare Conference

May 18, 2026, 4:00 PM EDT - 2 months ago

Waters Corporation to Present at the Jefferies Global Healthcare Conference

Waters price target raised to $350 from $330 at Deutsche Bank

2026-05-07T20:29:53.000Z - 2 months ago

Waters price target raised to $350 from $330 at Deutsche Bank

Waters price target raised to $425 from $400 at Barclays

2026-05-07T11:47:19.000Z - 2 months ago

Waters price target raised to $425 from $400 at Barclays

Waters price target raised to $387 from $362 at Baird

2026-05-07T09:02:41.000Z - 2 months ago

Waters price target raised to $387 from $362 at Baird

Waters price target raised to $345 from $330 at JPMorgan

2026-05-07T06:35:42.000Z - 2 months ago

Waters price target raised to $345 from $330 at JPMorgan

Waters price target raised to $385 from $345 at TD Cowen

2026-05-07T04:58:08.000Z - 2 months ago

Waters price target raised to $385 from $345 at TD Cowen

Waters price target raised to $375 from $330 at UBS

2026-05-07T03:54:17.000Z - 2 months ago

Waters price target raised to $375 from $330 at UBS

Waters CEO highlights China as key innovation source in the biopharma market

May 5, 2026, 6:47 PM EDT - 2 months ago

Waters CEO highlights China as key innovation source in the biopharma market

Waters raises annual profit forecast as biosciences unit drives growth

May 5, 2026, 10:38 AM EDT - 2 months ago

Waters raises annual profit forecast as biosciences unit drives growth

Waters Earnings Call Transcript: Q1 2026

May 5, 2026, 8:30 AM EDT - 2 months ago

Waters Earnings Call Transcript: Q1 2026

Waters Slides: Q1 2026

May 5, 2026, 8:30 AM EDT - 2 months ago

Waters Slides: Q1 2026

Waters Earnings release: Q1 2026

May 5, 2026, 8:30 AM EDT - 2 months ago

Waters Earnings release: Q1 2026

Waters Quarterly report: Q1 2026

May 5, 2026, 8:30 AM EDT - 2 months ago

Waters Quarterly report: Q1 2026

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

May 5, 2026, 6:00 AM EDT - 2 months ago

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

Apr 20, 2026, 4:15 PM EDT - 3 months ago

Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Apr 14, 2026, 8:00 AM EDT - 3 months ago

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Waters Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 3 months ago

Waters Proxy statement: Proxy filing

Waters Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 3 months ago

Waters Proxy statement: Proxy filing

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

Apr 8, 2026, 8:00 AM EDT - 3 months ago

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

Waters Prices Offering of Senior Notes

Mar 18, 2026, 6:00 AM EDT - 4 months ago

Waters Prices Offering of Senior Notes

Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed

Mar 9, 2026, 8:00 AM EDT - 4 months ago

Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed

Waters Transcript: TD Cowen 46th Annual Health Care Conference

Mar 2, 2026, 11:10 AM EST - 5 months ago

Waters Transcript: TD Cowen 46th Annual Health Care Conference

Waters Corporation to Present at the TD Cowen Health Care Conference

Feb 23, 2026, 4:45 PM EST - 5 months ago

Waters Corporation to Present at the TD Cowen Health Care Conference

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

Feb 17, 2026, 8:00 AM EST - 5 months ago

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

Feb 9, 2026, 8:40 AM EST - 5 months ago

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

BDX

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

Feb 9, 2026, 8:40 AM EST - 5 months ago

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

BDX

Waters Earnings Call Transcript: Q4 2025

Feb 9, 2026, 8:30 AM EST - 5 months ago

Waters Earnings Call Transcript: Q4 2025

Waters Annual report: Q4 2025

Feb 9, 2026, 8:30 AM EST - 5 months ago

Waters Annual report: Q4 2025

Waters Earnings release: Q4 2025

Feb 9, 2026, 8:30 AM EST - 5 months ago

Waters Earnings release: Q4 2025

Waters Slides: Q4 2025

Feb 9, 2026, 8:30 AM EST - 5 months ago

Waters Slides: Q4 2025

Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 9, 2026, 6:30 AM EST - 5 months ago

Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

Jan 27, 2026, 9:25 AM EST - 6 months ago

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

BDX

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

Jan 27, 2026, 9:25 AM EST - 6 months ago

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

BDX

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

Jan 20, 2026, 1:00 PM EST - 6 months ago

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

Waters Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 5:15 PM EST - 6 months ago

Waters Transcript: 44th Annual J.P. Morgan Healthcare Conference

Waters Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 5:15 PM EST - 6 months ago

Waters Slides: 44th Annual J.P. Morgan Healthcare Conference

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

Dec 23, 2025, 11:00 AM EST - 7 months ago

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

Waters Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 9:30 AM EST - 8 months ago

Waters Transcript: Jefferies London Healthcare Conference 2025

Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

Nov 11, 2025, 2:00 PM EST - 9 months ago

Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software

Nov 11, 2025, 8:00 AM EST - 9 months ago

Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software

Waters Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 9 months ago

Waters Earnings Call Transcript: Q3 2025

Waters Quarterly report: Q3 2025

Nov 4, 2025, 8:00 AM EST - 9 months ago

Waters Quarterly report: Q3 2025

Waters Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 9 months ago

Waters Earnings release: Q3 2025

Waters Slides: Q3 2025

Nov 4, 2025, 8:00 AM EST - 9 months ago

Waters Slides: Q3 2025

Waters Corp raises annual profit forecast on stronger lab equipment demand

Nov 4, 2025, 7:10 AM EST - 9 months ago

Waters Corp raises annual profit forecast on stronger lab equipment demand

Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results

Nov 4, 2025, 6:00 AM EST - 9 months ago

Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results

Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics

Oct 13, 2025, 8:05 AM EDT - 10 months ago

Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics

Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call

Oct 1, 2025, 12:00 PM EDT - 10 months ago

Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call

Waters Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 4, 2025, 9:30 AM EDT - 11 months ago

Waters Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Aug 26, 2025, 4:10 PM EDT - 11 months ago

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Waters Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings Call Transcript: Q2 2025

Waters Quarterly report: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Quarterly report: Q2 2025

Waters Earnings release: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings release: Q2 2025

Waters Slides: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Slides: Q2 2025

Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 6:00 AM EDT - 1 year ago

Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results

WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT

Jul 16, 2025, 11:33 AM EDT - 1 year ago

WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT

BDX

Top Stock Movers Now: Autodesk, Fortinet, Waters, and More

Jul 14, 2025, 1:05 PM EDT - 1 year ago

Top Stock Movers Now: Autodesk, Fortinet, Waters, and More

ADSK FTNT

Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal

Jul 14, 2025, 11:20 AM EDT - 1 year ago

Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal

Waters Transcript: M&A Announcement

Jul 14, 2025, 8:00 AM EDT - 1 year ago

Waters Transcript: M&A Announcement

Waters Press release: M&A Announcement

Jul 14, 2025, 8:00 AM EDT - 1 year ago

Waters Press release: M&A Announcement

Waters Slides: M&A Announcement

Jul 14, 2025, 8:00 AM EDT - 1 year ago

Waters Slides: M&A Announcement

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

Jul 14, 2025, 6:15 AM EDT - 1 year ago

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

BDX

Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call

Jul 11, 2025, 4:15 PM EDT - 1 year ago

Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity

Jun 17, 2025, 10:00 AM EDT - 1 year ago

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity

Waters Transcript: Jefferies Global Healthcare Conference 2025

Jun 4, 2025, 8:45 AM EDT - 1 year ago

Waters Transcript: Jefferies Global Healthcare Conference 2025

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality

May 28, 2025, 8:00 AM EDT - 1 year ago

Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality

Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio

May 21, 2025, 8:00 AM EDT - 1 year ago

Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio

Waters Corp's India business boosted by rush for weight-loss drugs

May 15, 2025, 7:48 AM EDT - 1 year ago

Waters Corp's India business boosted by rush for weight-loss drugs

Waters Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings Call Transcript: Q1 2025

Waters Quarterly report: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Quarterly report: Q1 2025

Waters Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings release: Q1 2025

Waters Slides: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Slides: Q1 2025

Waters raises 2025 profit forecast on resilient demand for lab equipment

May 6, 2025, 7:21 AM EDT - 1 year ago

Waters raises 2025 profit forecast on resilient demand for lab equipment

Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance

May 6, 2025, 6:15 AM EDT - 1 year ago

Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance

Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results

May 6, 2025, 6:00 AM EDT - 1 year ago

Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results

Waters Proxy statement: Proxy Filing

Apr 9, 2025, 8:00 AM EDT - 1 year ago

Waters Proxy statement: Proxy Filing

Waters Proxy statement: Proxy Filing

Apr 9, 2025, 8:00 AM EDT - 1 year ago

Waters Proxy statement: Proxy Filing

Waters Corporation Schedules First Quarter 2025 Earnings Conference Call

Apr 8, 2025, 4:30 PM EDT - 1 year ago

Waters Corporation Schedules First Quarter 2025 Earnings Conference Call

Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Waters Expands Alliance iS Bio HPLC Product Line with Photodiode Array Detector to Enhance Spectral Insights for Biopharma Development & QC

prismmarketview
prismmarketview Jul. 20 at 6:57 PM
Women's oncology is entering a new growth phase. A new PwC report projects the market could approach $110 billion by 2030, with investment increasingly expanding beyond breast cancer into ovarian, cervical and endometrial cancers. Our latest examines the trends driving the sector and highlights public companies advancing innovation across earlier detection, targeted therapies and immuno-oncology. $WAT $CORT $VSTM $IMNN $BLRX https://prismmarketview.com/womens-oncology-is-entering-its-next-growth-phase-as-investment-moves-beyond-breast-cancer/
0 · Reply
UpgradeDowngrade
UpgradeDowngrade Jul. 10 at 2:26 PM
$WAT RBC Capital Mkts has altered their rating of "Outperform" and target of "$435" see consensus outlook
0 · Reply
UpgradeDowngrade
UpgradeDowngrade Jun. 30 at 2:29 AM
$WAT Bernstein has altered their rating of "Outperform" and target of "$435" see consensus outlook
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 23 at 3:26 PM
$WAT Current Stock Price: $357.98 Contracts to trade: $360.0 WAT Jul 17 2026 Call Entry: $11.90 Exit: $20.68 ROI: 74% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 22 at 6:15 PM
$WAT Share Price: $357.77 Contract Selected: Jan 15, 2027 $360 Calls Buy Zone: $31.62 – $39.06 Target Zone: $56.95 – $69.60 Potential Upside: 70% ROI Time to Expiration: 206 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BreakoutsHappen
BreakoutsHappen Jun. 5 at 4:51 AM
Watchlist Today $ILMN $CZR $LSTR $WAT https://breakoutshappen.com/scanners/vcp-scanner
0 · Reply
JFDI
JFDI Jun. 3 at 4:58 PM
$WAT big ol base
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Jun. 1 at 6:44 PM
$WAT These medical device stocks have 2 to 3 Green Day’s per month
0 · Reply
flychicken1991
flychicken1991 Jun. 1 at 12:06 PM
news impact: Waters unveiled the Cyclic IMS P20 MS platform for structural and spatial omics, putting instrument adoption and lab workflow upgrades in focus. NewsImpact map: https://clawpool.hihired.org/newsimpact/?ticker=WAT&utm_source=stocktwits&utm_medium=parent_url Watch launch timing, customer uptake, omics workflow demand, margin mix, and life-science tools peer reaction. Not financial advice.$WAT
0 · Reply
Skusek
Skusek May. 31 at 11:21 PM
$WAT Target 400-450$
0 · Reply
Doozio
Doozio May. 30 at 4:59 PM
Chop chop huckleberries. Know $WAT ? It was always ONTO 🐒🍌🧠⏰♾️ because he gave da sign n is wUtchin.
0 · Reply
BillionerOfKing
BillionerOfKing May. 26 at 4:14 AM
$WAT Current Stock Price: $342.38 Contracts to trade: $340.0 WAT Jun 18 2026 Call Entry: $11.10 Exit: $19.89 ROI: 79% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
CapitalMonk
CapitalMonk May. 25 at 5:56 PM
$WAT Price: $342.37 (+0.40%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±1.75% RSI: 70.0 | Momentum: Strong Momentum Volume: -59.3% vs avg Volatility: 3.82% Support: $287.19 | Resistance: $357.45 Sourch: http://marketbaubles.com/
0 · Reply
CapitalMonk
CapitalMonk May. 21 at 6:15 PM
$WAT Price: $341.32 (-0.00%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.11% RSI: 66.3 | Momentum: Strong Momentum Volume: -82.2% vs avg Volatility: 3.83% Support: $287.19 | Resistance: $357.45 Sourch: http://marketbaubles.com/
0 · Reply
Quant73
Quant73 May. 12 at 4:14 PM
$ISRG Great breakdown of whats happening with $IHI stocks on Griffonomics. $WAT $DHR $SYK Very Bullish for $ISRG https://www.youtube.com/watch?v=7jv0vDOmlV8
0 · Reply
BillionerOfKing
BillionerOfKing May. 8 at 5:27 AM
$WAT Current Stock Price: $350.49 Contracts to trade: $350.0 WAT May 15 2026 Call Entry: $3.60 Exit: $5.25 ROI: 46% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 10:53 PM
$WAT Current Stock Price: $349.17 Contracts to trade: $350.0 WAT May 15 2026 Call Entry: $4.70 Exit: $9.34 ROI: 99% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
DonCorleone77
DonCorleone77 May. 5 at 1:22 PM
$PINS $IART $WAT $ROK $BUD PRE-MARKET MOVERS: Currently Higher After Earnings: - Pinterest (PINS) up 19.2% - Integra LifeSciences (IART) up 15.5% - Waters (WAT) up 9.3% - Rockwell Automation (ROK) up 8.4% - AB InBev (BUD) up 7.2% - DuPont (DD) up 1.3% - Cummins (CMI) up 5.3% - KKR (KKR) up 1.4% - GlobalFoundries (GFS) up 3.5% - Archer Daniels (ADM) up 0.1% - Leidos (LDOS) up 1.1% Currently Also Higher: - Intel (INTC) up 4.0% after Bloomberg reported Apple (AAPL) has held discussions on using Intel and Samsung (SSNLF) to produce the main processors for its U.S. devices - Coinbase (COIN) up 3.6% after announcing plans to cut workforce by 14%, or 700 employees - Kopin (KOPN) up 11.9% after being awarded $21.5M follow-on production contract Currently Lower After Earnings: - Fabrinet (FN) down 11.7% - Fiserv (FISV) down 7.9% - PayPal (PYPL) down 9.4% - Shopify (SHOP) down 7.7% - On Semi (ON) down 4.4% - Eaton (ETN) down 5.5% - Duolingo (DUOL) down 5.7% - Palantir (PLTR) down 2.1%
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 5 at 10:16 AM
$WAT Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.87 down -142.65% YoY • Reported revenue of $1.27B up 91.48% YoY • Waters Corporation is raising its full-year 2026 organic constant currency revenue growth guidance to 6.5% to 8.0% and adjusted EPS guidance to $14.40 to $14.60.
0 · Reply
CapitalMonk
CapitalMonk May. 5 at 3:31 AM
$WAT Price: $301.88 (-1.71%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.74% RSI: 35.2 | Momentum: Strong Downside Volume: -6.8% vs avg Volatility: 2.77% Support: $287.19 | Resistance: $346.78 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
AnthonyTradingWithJesus
AnthonyTradingWithJesus Apr. 26 at 10:32 PM
$LULU $BLK $CLSK $WAT $GRPN
0 · Reply
knowinvest
knowinvest Apr. 23 at 1:47 PM
$WAT looks like earning number leaked and some insider affiliates sold
0 · Reply